Gen-Probe Targets 2011 for HPV Test in US; HIA Put on Backburner | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe is targeting a 2011 launch in the US for its molecular diagnostic assay for human papillomavirus, CFO Herm Rosenman told investors Wednesday afternoon at the UBS Global Life Sciences Conference.

The San Diego-based firm received the CE Mark and launched the Aptima HPV Assay in Europe in May. The test runs on its Tigris instrument system, which Rosenman said is the only fully automated molecular diagnostics instrument on the market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.